secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK:        0000771856
Form:       8-K
Filed at:   2025-07-23T23:59:59+00:00
Accession:  0001628280-25-035727
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Champions Oncology reports record annual revenue $57M (+14%), net income $4.6M for FY2025
--------------------------------------------------------------------------------

- Record annual revenue $57M, up 14% YoY; net income $4.6M vs loss of $7.4M prior year.
- Adjusted EBITDA income $7.1M (vs loss of $3.9M); year-end cash $9.8M with no debt.
- Q4 revenue $12.3M, down 12% YoY; Q4 adjusted EBITDA loss of $1.2M.
- Data license revenue contributed $4.7M for fiscal year; new high-margin data business launched.
- CEO cites return to growth and profitability; strong pipeline for FY2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/771856/000162828025035727/0001628280-25-035727-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/771856/000162828025035727/csbr-20250723.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-035727

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer